Xiaowen Wu - Concepedia

Author

Xiaowen Wu

Peking University Cancer Hospital ORCID

Also Known As

Wu, Xiaowen, X Wu, X. Wu, Xiao-Wen WU, Xiao-Wen Wu, Xiao-wen Wu, XiaoWen Wu, Xiaowen Wu

134

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Peking University Cancer Hospital Peking University Ministry of Education Northwest A&F University Tianjin Medical University

About

Xiaowen Wu is an author at Peking University Cancer Hospital specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	188
2	Engineering	3	3	62
3	Natural Sciences	2	2	27
4	Biochemistry	2	2	28
5	Health Sciences	1	1	23

Xiaowen Wu

Publications

Citations

H-Index

Page 1

	Year	Citations
Invasion of Spartina alterniflora Enhanced Ecosystem Carbon and Nitrogen Stocks in the Yangtze Estuary, China Chengzhang Liao, Yiqi Luo, Lifen Jiang, Ecosystems Nitrogen StocksBiogeochemistryEstuarine GeochemistryYangtze EstuaryEstuary	2007	280
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients Jiayi Yu, Xiaowen Wu, Junya Yan, Journal of Hematology & Oncology	2018	183
Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance Jianjun Cao, Xiaowen Wu, Cai‐Ping Tan, Journal of Medicinal Chemistry	2019	132
Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy Yan Kong, Xinan Sheng, Xiaowen Wu, Clinical Cancer Research	2017	115
Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma Jiayi Yu, Junya Yan, Qian Guo, Clinical Cancer Research	2019	107
Analysis of <i>mTOR</i> Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors Yan Kong, Lu Si, Yiqian Li, Clinical Cancer Research	2015	83
MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways Meng Ma, Jie Dai, Huan Tang, Theranostics	2019	66
Synergistic and targeted drug delivery based on nano-CeO<sub>2</sub> capped with galactose functionalized pillar[5]arene via host–guest interactions Xiaowen Wu, Ying Zhang, Yuchao Lu, Journal of Materials Chemistry B	2017	55
Dual-responsive dithio-polydopamine coated porous CeO<sub>2</sub> nanorods for targeted and synergistic drug delivery Ying Zhang, Xiaowen Wu, Chenxi Hou, International Journal of Nanomedicine	2018	49
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis Siming Li, Xiaowen Wu, Xieqiao Yan, Journal for ImmunoTherapy of Cancer	2022	48

Page 1